Published in Radiology on May 01, 2008
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int (2010) 5.02
Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med (2012) 1.71
Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging. Radiology (2014) 1.52
Combined PET/MRI: a new dimension in whole-body oncology imaging? Eur J Nucl Med Mol Imaging (2009) 1.41
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology (2014) 1.33
Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol (2010) 1.31
APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review. Int J Hepatol (2011) 1.24
Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis. Eur Radiol (2011) 1.22
Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Eur Radiol (2009) 1.16
Diffusion weighted imaging in the liver. World J Gastroenterol (2010) 1.15
Association between hepatitis C and hepatocellular carcinoma. J Glob Infect Dis (2009) 1.15
Infiltrating hepatocellular carcinoma: seeing the tree through the forest. J Gastrointest Surg (2011) 1.11
Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes. Ann Surg Oncol (2012) 1.11
Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging (2012) 1.08
How I do it: Cone-beam CT during transarterial chemoembolization for liver cancer. Radiology (2015) 1.04
Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging (2013) 1.00
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology (2014) 1.00
The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma. Eur J Nucl Med Mol Imaging (2011) 1.00
Primary clear cell carcinoma in the liver: CT and MRI findings. World J Gastroenterol (2011) 0.98
Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome. World J Hepatol (2015) 0.96
Histologic characteristics of hepatocellular carcinomas showing atypical enhancement patterns on 4-phase MDCT examination. Korean J Radiol (2012) 0.95
Radiofrequency ablation of small liver malignancies under magnetic resonance guidance: progress in targeting and preliminary observations with temperature monitoring. Eur Radiol (2009) 0.95
Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT. Br J Radiol (2011) 0.94
Hepatobiliary contrast agents: differential diagnosis of focal hepatic lesions, pitfalls and other indications. Radiol Bras (2015) 0.93
Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI. Br J Radiol (2012) 0.89
Liver Imaging Reporting and Data System: an expert consensus statement. J Hepatocell Carcinoma (2017) 0.88
DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility. J Magn Reson Imaging (2013) 0.88
Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging. World J Gastroenterol (2013) 0.85
Diagnostic and therapeutic management of hepatocellular carcinoma. World J Gastroenterol (2015) 0.85
Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome. World J Gastroenterol (2014) 0.85
Dynamic contrast-enhanced CT imaging of hepatocellular carcinoma in cirrhosis: feasibility of a prolonged dual-phase imaging protocol with tracer kinetics modeling. Eur Radiol (2009) 0.83
Hepatocellular carcinoma: development and early detection. Cancer Imaging (2008) 0.82
Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) (2013) 0.82
Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis. World J Hepatol (2009) 0.81
MRI of hepatocellular carcinoma: an update of current practices. Diagn Interv Radiol (2014) 0.81
The utility of gadoxetic acid-enhanced MR imaging to characterize atypical cirrhotic nodules detected on dynamic CT images. PLoS One (2014) 0.81
Evaluation of anatomical landmark position differences between respiration-gated MRI and four-dimensional CT for radiation therapy in patients with hepatocellular carcinoma. Br J Radiol (2013) 0.80
Recent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRI. Liver Cancer (2015) 0.79
Incidence, Characteristics, and Prognosis of Incidentally Discovered Hepatocellular Carcinoma after Liver Transplantation. J Transplant (2016) 0.79
Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study. J Gastroenterol (2015) 0.79
Optimising the scan delay for arterial phase imaging of the liver using the bolus tracking technique. Biomed Imaging Interv J (2011) 0.79
Transarterial chemoembolization of hepatocellular carcinoma with segmental portal vein tumour thrombus. Eur Radiol (2016) 0.79
Magnetic resonance imaging of the cirrhotic liver: An update. World J Hepatol (2015) 0.78
Grading of small hepatocellular carcinomas (≤2 cm): correlation between histology, T2 and diffusion-weighted imaging. Br J Radiol (2014) 0.78
Detection of recurrent hepatocellular carcinoma in cirrhotic liver after transcatheter arterial chemoembolization: value of quantitative color mapping of the arterial enhancement fraction of the liver. Korean J Radiol (2012) 0.78
Quantitative hepatic perfusion modeling using DCE-MRI with sequential breathholds. J Magn Reson Imaging (2013) 0.78
Morbidity of hepatic resection for intermediate and advanced hepatocellular carcinoma. Langenbecks Arch Surg (2015) 0.78
Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol. Eur Radiol (2015) 0.78
Evaluation of a method for improving the detection of hepatocellular carcinoma. Eur Radiol (2013) 0.77
Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol (2016) 0.77
Contrast Enhanced MRI in the Diagnosis of HCC. Diagnostics (Basel) (2015) 0.76
Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma. World J Gastroenterol (2016) 0.76
Non-invasive diagnosis of abdomino-pelvic masses: role of multimodality imaging. J Clin Imaging Sci (2013) 0.76
Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI. Br J Radiol (2010) 0.75
The role of the diffusion sequence in magnetic resonance imaging for the differential diagnosis between hepatocellular carcinoma and benign liver lesions. Clujul Med (2016) 0.75
DCE-MRI of hepatocellular carcinoma: perfusion quantification with Tofts model versus shutter-speed model-initial experience. MAGMA (2015) 0.75
Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update. Infect Agent Cancer (2017) 0.75
MR imaging in liver cirrhosis: classical and new approaches. Insights Imaging (2010) 0.75
The growing epidemic of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) (2008) 0.75
MDCT of abdominopelvic oncologic emergencies. Cancer Imaging (2013) 0.75
Clinical research on alternating hyperfraction radiotherapy for massive hepatocellular carcinoma. Oncol Lett (2015) 0.75
Regression of Hypervascular Nodules in a Patient with Wilson's Disease Awaiting Liver Transplantation. J Transplant (2009) 0.75
Demonstration of metabolic and cellular effects of portal vein ligation using multi-modal PET/MRI measurements in healthy rat liver. PLoS One (2014) 0.75
Critical analysis of the major and ancillary imaging features of LI-RADS on 127 proven HCCs evaluated with functional and morphological MRI: Lights and shadows. Oncotarget (2017) 0.75
Detection of urine DNA markers for monitoring recurrent hepatocellular carcinoma. Hepatoma Res (2017) 0.75
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology (2003) 16.40
Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology (2008) 4.73
Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail? Am J Gastroenterol (2013) 3.41
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. J Hepatol (2012) 3.04
New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology (2013) 2.76
Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience. Radiology (2005) 2.69
The relationship between anterior and apical compartment support. Am J Obstet Gynecol (2006) 2.65
Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev (2012) 2.57
Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology (2012) 2.53
Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One (2011) 2.48
Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys (2007) 2.33
Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation. J Hepatol (2005) 2.26
Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease. Radiology (2011) 2.04
Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. Hepatology (2011) 1.98
Modified Charlson comorbidity index for predicting survival after liver transplantation. Liver Transpl (2007) 1.96
Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology (2011) 1.94
Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases. Hepatology (2010) 1.80
Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. Cancer Biomark (2007) 1.65
Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence. Liver Transpl (2007) 1.61
Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer. Cancer Res (2005) 1.55
SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology (2005) 1.55
Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging. Radiology (2014) 1.52
Renal outcomes after liver transplantation in the model for end-stage liver disease era. Liver Transpl (2009) 1.49
Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res (Phila) (2012) 1.49
Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl (2005) 1.47
Primovist, Eovist: what to expect? J Hepatol (2012) 1.46
Patient involvement in healthcare is associated with higher rates of surveillance for hepatocellular carcinoma. J Clin Gastroenterol (2011) 1.46
Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology (2012) 1.44
Improved post-transplant survival in the United States for patients with cholangiocarcinoma after 2000. Dig Dis Sci (2013) 1.43
Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer. Clin Cancer Res (2003) 1.40
Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinoma. Am J Gastroenterol (2013) 1.39
Two-color, rolling-circle amplification on antibody microarrays for sensitive, multiplexed serum-protein measurements. Genome Biol (2004) 1.39
Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl (2010) 1.38
Characterization of pancreatic tumor motion using cine MRI: surrogates for tumor position should be used with caution. Int J Radiat Oncol Biol Phys (2009) 1.34
Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. J Virol (2007) 1.33
An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl (2009) 1.31
Frequency, management, and outcome of extravasation of nonionic iodinated contrast medium in 69,657 intravenous injections. Radiology (2007) 1.31
Levator plate angle in women with pelvic organ prolapse compared to women with normal support using dynamic MR imaging. Am J Obstet Gynecol (2006) 1.27
Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique. AJR Am J Roentgenol (2006) 1.17
Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol (2013) 1.11
Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol (2010) 1.09
Müllerian duct anomalies: comparison of MRI diagnosis and clinical diagnosis. AJR Am J Roentgenol (2007) 1.09
MR imaging and CT of the biliary tract. Radiographics (2009) 1.08
Early detection of liver cancer: diagnosis and management. Curr Gastroenterol Rep (2008) 1.05
Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment. AJR Am J Roentgenol (2002) 1.03
Nephrogenic systemic fibrosis: a report of 29 cases. AJR Am J Roentgenol (2008) 0.99
MRI of sonographically indeterminate adnexal masses. AJR Am J Roentgenol (2006) 0.98
Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol (2013) 0.97
Effectiveness of MR imaging in characterizing small hepatic lesions: routine versus expert interpretation. AJR Am J Roentgenol (2003) 0.97
Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver. J Magn Reson Imaging (2010) 0.96
Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists. Dig Dis Sci (2010) 0.94
Current approaches to the treatment of early hepatocellular carcinoma. Oncologist (2010) 0.93
Preoperative MR angiography in free fibula flap transfer for head and neck cancer: clinical application and influence on surgical decision making. AJR Am J Roentgenol (2007) 0.93
Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine. Radiology (2014) 0.92
Staging systems for hepatocellular carcinoma: should we all use the BCLC system? J Hepatol (2006) 0.92
Effectiveness of interferon alpha-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice. Clin Gastroenterol Hepatol (2004) 0.92
Rectal imaging: part 2, Perianal fistula evaluation on pelvic MRI--what the radiologist needs to know. AJR Am J Roentgenol (2012) 0.92
Screening process failures for hepatocellular carcinoma. J Natl Compr Canc Netw (2014) 0.90
Hepatocellular carcinoma. Curr Opin Gastroenterol (2004) 0.90
Viral hepatitis and hepatocellular carcinoma. Arch Med Res (2007) 0.90
Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient? Acad Radiol (2002) 0.90
MRI for preoperative staging of renal cell carcinoma using the 1997 TNM classification: comparison with surgical and pathologic staging. AJR Am J Roentgenol (2004) 0.89
Visualization of the biliary tract using gadobenate dimeglumine: preliminary findings. J Comput Assist Tomogr (2008) 0.89
Abdominal applications of diffusion-weighted magnetic resonance imaging: Where do we stand. World J Radiol (2013) 0.88
Possible biliary disease: diagnostic performance of high-spatial-resolution isotropic 3D T2-weighted MRCP. Radiology (2008) 0.88
Effect of abrupt substitution of gadobenate dimeglumine for gadopentetate dimeglumine on rate of allergic-like reactions. Radiology (2012) 0.88
Making cost-effectiveness analyses clinically relevant: the effect of provider expertise and biliary disease prevalence on the economic comparison of alternative diagnostic strategies. Acad Radiol (2003) 0.88
Dose-toxicity relationship of gadoxetate disodium and transient severe respiratory motion artifact. AJR Am J Roentgenol (2014) 0.87
Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma. Transplantation (2006) 0.86
Magnetic Resonance Imaging of cholangiocarcinoma. Cancer Imaging (2004) 0.86
Occult hepatitis B virus infection in patients with hepatocellular carcinoma: Innocent bystander, cofactor, or culprit? Gastroenterology (2004) 0.85
Diffusion-weighted MR imaging of the liver at 3.0 Tesla using TRacking Only Navigator echo (TRON): a feasibility study. J Magn Reson Imaging (2009) 0.85
Contrast-enhanced CT accurately detects hemorrhage in torso trauma: direct comparison with angiography. J Trauma (2007) 0.84
A multidisciplinary approach to the management of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) (2010) 0.84
Safety of gadolinium-based contrast material in sickle cell disease. J Magn Reson Imaging (2011) 0.83
Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma. J Natl Compr Canc Netw (2013) 0.82
Developing a prediction rule to assess hepatic malignancy in patients with cirrhosis. AJR Am J Roentgenol (2003) 0.82
Consensus report from the 6th International forum for liver MRI using gadoxetic acid. J Magn Reson Imaging (2013) 0.82
Magnetic resonance characterization of pheochromocytomas in the abdomen and pelvis: imaging findings in 18 surgically proven cases. J Comput Assist Tomogr (2010) 0.82
Sonography of uterine abnormalities in postpartum and postabortion patients: a potential pitfall of interpretation. J Ultrasound Med (2008) 0.81
3D excretory MR urography: improved image quality with intravenous saline and diuretic administration. J Magn Reson Imaging (2007) 0.81
Effect of contrast media on single-shot echo planar imaging: implications for abdominal diffusion imaging. J Magn Reson Imaging (2009) 0.80
Magnetic resonance imaging in cirrhosis: what's new? Top Magn Reson Imaging (2014) 0.80
Role of liver transplantation in the treatment of cholangiocarcinoma. Expert Rev Anticancer Ther (2009) 0.80
Elevated serum IL-8 is associated with the presence of hepatocellular carcinoma and independently predicts survival. Cancer Invest (2012) 0.79
MR imaging in the characterization of small renal masses. Abdom Imaging (2014) 0.79
Dynamic MRI evaluation of urethral hypermobility post-radical prostatectomy. Neurourol Urodyn (2013) 0.78
Can dietary fish intake prevent liver cancer? Gastroenterology (2012) 0.78
Alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology (2009) 0.78
Contemporary and emerging technologies in abdominal magnetic resonance imaging. Semin Roentgenol (2013) 0.78
Interferon therapy and prevention of hepatocellular carcinoma in hepatitis C. Dig Dis Sci (2012) 0.77
Immune thrombocytopenic purpura following liver transplantation: a case series and review of the literature. Liver Transpl (2006) 0.77
MR imaging of the small bowel in Crohn disease. Magn Reson Imaging Clin N Am (2014) 0.76
Donor factors similarly impact survival outcome after liver transplantation in hepatocellular carcinoma and non-hepatocellular carcinoma patients. Dig Dis Sci (2014) 0.76
Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed? Gastroenterology (2008) 0.76
Concomitant resorptive defects of the reproductive tract: a uterocervicovaginal septum and imperforate hymen. Fertil Steril (2009) 0.76